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Plasma homocysteine (Hcy) level is associated with cardiovascular disease and may play an etiologic role in
vascular damage, a precursor for atherosclerosis. We performed a genome-wide association study for Hcy in
1786 unrelated Filipino women from the Cebu Longitudinal Health and Nutrition Survey (CLHNS). The most
strongly associated single-nucleotide polymorphism (SNP) (rs7422339, P 5 4.7 3 10213) encodes
Thr1405Asn in the gene CPS1 and explained 3.0% of variation in the Hcy level. The widely studied MTHFR
C677T SNP (rs1801133) was also highly significant (P 5 8.7 3 10210) and explained 1.6% of the trait variation.
We also genotyped these two SNPs in 1679 CLHNS young adult offspring. The MTHFR C677T SNP was
strongly associated with Hcy (P 5 1.9 3 10226) and explained ∼5.1% of the variation in the offspring. In con-
trast, the CPS1 variant was significant only in females (P 5 0.11 in all; P 5 0.0087 in females). Combined
analysis of all samples confirmed that the MTHFR variant was more strongly associated with Hcy in the off-
spring (interaction P 5 1.2 3 1025). Furthermore, although there was evidence for a positive synergistic effect
between the CPS1 and MTHFR SNPs in the offspring (interaction P 5 0.0046), there was no significant evi-
dence for an interaction in the mothers (P 5 0.55). These data confirm a recent finding that CPS1 is a
locus influencing Hcy levels in women and suggest that genetic effects on Hcy may differ across develop-
mental stages.
INTRODUCTION
Homocysteine (Hcy) is a sulfur-containing amino acid pro-
duced in the metabolism of the essential amino acid methion-
ine, which occurs through folic acid and vitamin B6- and
vitamin B12-dependent pathways (1). Increased blood plasma
Hcy levels have been shown to be a risk factor for cardiovas-
cular disease (CVD) and may play an etiologic role in vascular
damage by promoting oxidative stress, systemic inflammation
and endothelial dysfunction (2). Numerous epidemiologic
studies have reported that elevated Hcy is associated with
both subclinical and clinical CVD, and evidence supports
that the increased risk is independent of other atherosclerosis
risk factors (3–8).
Genetic factors play a substantial role in Hcy levels, but
whether the same variants influence Hcy across populations
is unknown. Heritability estimates range from 47–70%
across several genetic and environmental backgrounds
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(9–11). The most well-studied gene containing variants
associated with Hcy levels is methylene tetrahydrofolate
reductase (MTHFR), which encodes a key enzyme in folic
acid metabolism and was first identified as the causal gene
for three rare autosomal homocysteinurias (12). A
meta-analysis of the MTHFR C677T variant (rs1801133) in
33 studies representing 35 populations showed a mean differ-
ence in serum Hcy between the TT and CC genotypes of
2.7 mmol/L (2.1–3.4 mmol/L) and between the CT and CC
genotypes of 0.29 mmol/L (0.20–0.39 mmol/L) (8). More
recently, genome-wide association (GWA) studies for Hcy
levels in populations of European descent identified novel
loci (13,14).
To further clarify the genetic contributions to normal vari-
ation in Hcy in a population of primarily non-European
descent, we performed a GWA study of the Hcy level in
mothers from the Cebu Longitudinal Health and Nutrition
Survey (CLHNS), using single-nucleotide polymorphism
(SNP) data on 1786 women from Cebu, the Philippines. We
also genotyped selected SNPs and tested them for association
with the Hcy level in their young adult offspring to further
evaluate genetic effects in males and across a wider age range.
RESULTS
GWA results in CLHNS mothers
In 1786 CLHNS mothers with complete genotype and pheno-
type data (Supplementary Material, Table S1), we observed 22
SNPs significantly associated with natural log-transformed
Hcy (log-Hcy) levels (P , 5  1028), all located within or
near the carbamoyl phosphate synthetase 1 (CPS1) gene on
chromosome 2 (Fig. 1). The most strongly associated SNP
(rs7422339, P ¼ 4.7  10213) was imputed, and encodes a
Thr1405Asn substitution. Tests of association for the other
CPS1 SNPs conditional on rs7422339 suggested a single
CPS1 signal. The most significant SNP outside the CPS1
region was rs6722617 (P ¼ 1.9  1027), an imputed SNP
located on chromosome 2q11.2 near lysozyme G-like 1
(LYG1) and thioredoxin domain containing 9 (TXNDC9),
neither of which has been previously implicated as having
effects on Hcy or other CVD-related traits. Several MTHFR
SNPs showed modest evidence of association (best P ¼
2.7  1024 for rs13306561). However, the widely studied
MTHFR C677T variant (rs1801133) was not directly tested
as part of the genome-wide panel, and the imputation quality
score did not meet the minimum requirement for inclusion
in analysis.
Four analyses showed little-to-no evidence for genetic het-
erogeneity among CLHNS subjects: principal component
(PC) analysis of population substructure (Supplementary
Material, Fig. S1), a minimal effect of adjusting for PCs
(data not shown), the observed genomic control inflation
factor (lGC) of 1.0 and a quantile–quantile plot of GWA
P-values (Fig. 2).
Follow-up genotyping
The most significant variants in the CPS1 and LYG1-TXNDC9
regions were both imputed SNPs. To confirm association in
the mothers and to test these variants for association with
log-Hcy in the offspring (n ¼ 1679; 54.8% male, Supplemen-
tary Material, Table S2), we directly genotyped rs7422339 and
rs6722617. We also genotyped the MTHFR SNP rs1801133 in
both the mothers and the offspring.
The test of association between log-Hcy and the directly
genotyped CPS1 SNP rs7422339 remained significant in the
CLHNS mothers (P ¼ 5.3  10212, Table 1). The estimated
increase in log-Hcy for each additional A allele was 0.071
[standard error (SE) ¼ 0.009], and the proportion of variability
in the log-Hcy level explained by genotype was 3.0%. This
Figure 1. GWA results for log-Hcy levels in 1786 CLHNS mothers. Result for directly genotyped SNP rs1801133 (MTHFR) is included. Loci described in the
text are annotated with gene symbols.
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SNP was not significantly associated with log-Hcy levels (P ¼
0.11) in the pooled CLHNS offspring sample (Table 1).
However, evidence for association was present in the
female-only subset (n ¼ 759; P ¼ 0.0087), with the direction
of effect the same as observed in the mothers (increase of
0.040 in mean log-Hcy for each additional A allele). A
formal test for a gender-by-genotype interaction in the
offspring-only sample was not significant (P ¼ 0.095), but
the statistical power to detect such an interaction was only
54% for the effect size observed. The test for interaction
between rs7422339 genotype and generation (mothers versus
offspring) was significant (P ¼ 0.0004). There was no signifi-
cant evidence for an interaction between age and genotype in
the mothers (P . 0.10).
Evidence of log-Hcy association for the directly genotyped
LYG1-TXNDC9 SNP rs6722617 (P ¼ 1.2  1027) was similar
to the result based on its imputed genotype. The estimated
increase for log-Hcy was 0.62 (SE ¼ 0.23) for each additional
C allele. No evidence for association between rs6722617 and
log-Hcy was observed in the offspring-only sample (P ¼
0.58).
The directly genotyped MTHFR C677T SNP showed con-
vincing evidence of association (P ¼ 8.7  10210) and
explained 1.6% of the proportion of variability in log-Hcy in
the CLHNS mothers (Table 1). The estimated increase in
log-Hcy for each additional copy of the T allele was 0.083
(SE ¼ 0.015). This SNP was even more strongly associated
with log-Hcy levels in the gender-combined offspring
sample (P ¼ 1.9  10226, Table 1). Each additional copy of
the T allele was associated with an increase in log-Hcy of
0.171 (SE ¼ 0.016), and the proportion of variability in the
log-Hcy level explained by this locus was 5.1%. The gender-
stratified results in the CLHNS offspring indicated that the
MTHFR C677T association appeared slightly stronger in
males (P ¼ 1.1  10216; b ¼ 0.199; R2 ¼ 7.3%) than
females (P ¼ 3.6  10210; b ¼ 0.136; R2 ¼ 5.1%), and there
was marginal evidence for a gender-by-genotype interaction
(P ¼ 0.053). The combined study of mothers and offspring
for MTHFR C677T resulted in a smaller P-value (P ¼ 1.3 
10229) than when analyses were restricted to the offspring
alone. Evidence for an interaction between genotype and gen-
eration (P ¼ 1.2  1025) suggests that the increase in mean
log-Hcy levels associated with each additional T allele is
greater in the offspring cohort than in the mothers, although
this result may be somewhat confounded by the marginal evi-
dence for a gender interaction in the offspring. We did not
observe evidence for an interaction between age and genotype
in the mothers (P . 0.10). The MTHFR C677T genotypic
means in the CLHNS mothers and offspring are most consist-
ent with a recessive model for the T allele. The sample sizes
for the 677T homozygotes (n ¼ 7 for mothers and n ¼ 16
for offspring), however, were too small to test this model.
Additional covariate adjustment for estimated folate,
vitamin B6 and vitamin B12 intake levels in our linear
models did not appreciably change any tests of genotype
association or genetic effect size estimates for CPS1
rs7422339 or MTHFR C677T in either the CLHNS mother
or offspring cohorts (data not shown). Furthermore, we
found no evidence of interaction between MTHFR C677T gen-
otype and dietary intake levels of folate (data not shown).
Replication of previously identified loci
To investigate whether this Filipino sample replicated evi-
dence for loci reported (P , 1  1026) in a GWA scan for
Hcy in white American women (13), we defined positive evi-
dence for replication as P , 0.10, with an effect size in the
same direction as observed for the original study (i.e. one-
sided test with a ¼ 0.05). In addition to MTHFR and CPS1,
which showed stronger estimated effects in the CLHNS,
association signals were replicated with similar effect sizes
in NOX4, CHMPIA-DPEP1 and CENPQ-MUT, but not
AKAP13, nor a second signal near MTHFR (Table 2). For
the reported CBS signal, neither the SNP nor a suitable
proxy was available in the CLHNS samples.
Multi-locus association results
We examined additive and interaction effects for SNPs at the
CPS1 and MTHFR loci in the CLHNS mothers. The cumulat-
ive proportion of variability explained by rs7422339 and
rs1801133 was 4.7% in the CLHNS mothers, and there was
no evidence for an interaction between the two loci (P ¼
0.30). However in the offspring sample, the test of interaction
between the loci was statistically significant (P ¼ 0.0046). The
cumulative proportion of variance of log-Hcy explained by
both loci and their interaction in the offspring sample was
5.8%. We also estimated the cumulative proportion of
log-Hcy variability explained by five loci reported previously
(13) that had at least nominal evidence of significance in the
CLHNS mothers (CPS1 rs7422339, MTHFR rs1801133,
NOX4 rs11018628, CHMPIA-DPEP1 rs460879 and
CENPQ-MUT rs4267943) to be 5.9%.
Figure 2. Quantile–quantile plot of SNP association with log-Hcy in CLHNS
mothers. Black closed circles indicate all SNPs and dark-gray closed circles
exclude all SNPs in 1 Mb windows centered on each previously reported
SNP associated with log-Hcy (Table 2). A solid black line indicates the
uniform expectation and the gray dashed lines indicate the 95% prediction
interval.
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Association of CPS1 rs7422339 genotype with other
CVD-related traits
To characterize the CPS1 gene with respect to associations
with CVD-related phenotypes, we further evaluated other
possible effects of the rs7422339 SNP and additional traits
of total cholesterol, high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C), trigly-
cerides, C-reactive protein (CRP), fasting glucose and body
mass index (BMI) in the CLHNS mothers (Supplementary
Material, Table S3). The A allele of rs7422339 was nominally
associated with higher LDL-C (P ¼ 0.0010) and higher total
cholesterol (P ¼ 0.0094). After adjustment for Hcy, the
P-value for LDL-C was 0.021, suggesting that rs7422339
may have some effect on LDL-C independent of Hcy. No evi-
dence for association was observed between rs7422339 and
total cholesterol after adjustment for Hcy (P ¼ 0.11).
Discussion
We observed strong evidence for association between CPS1
variation and log-Hcy level in this GWA study of 1786 Fili-
pino mothers from the CLHNS cohort. The most significantly
associated SNP (P ¼ 4.7  10213) encodes Thr1405Asn in
CPS1 and explains 3% of the variability in log-Hcy levels
in this cohort. This finding confirms a recent report by the
Women’s Genome Health Study (WGHS), which observed
significant evidence for an association between Hcy levels
and rs7422339 (P ¼ 1.9  10211) in a sample of 13 974 Cau-
casian women. The protein encoded by CPS1 catalyzes the
first committed step of the hepatic urea cycle, and
rs7422339 has been previously reported to be associated
with nitric oxide level and vascular smooth muscle activity,
necrotizing enterocolitis, pulmonary hypertension and, also
in the WGHS, fibrinogen level (15–18). Consistent with our
evidence of association in the female but not male CLHNS
offspring, the WGHS did not observe replication evidence
for CPS1 in samples from the Precocious Coronary Artery
Disease Study (PROCARDIS), a subset of 840 post-
myocardial infarction patients from several European
countries, until they performed a gender-stratified analysis
(male n ¼ 658, P . 0.05; female n ¼ 161, P ¼ 0.0009).
Although the P-value for gender-by-genotype interaction in
the CLHNS offspring was not statistically significant (P ¼
0.095), together these results suggest that the effects of this
gene may be stronger in women than in men.
The CLHNS mothers also showed evidence for association
with the widely studied MTHFR C677T SNP (rs1801133),
which explained an estimated 1.6% of the variation in
log-Hcy levels. Follow-up analysis of the CLHNS young
adult offspring (age 20–22 years) suggests that MTHFR
C677T has a much stronger effect in this younger generation,
with an estimated proportion of variance explained by geno-
type of 6.3%, which is very large for a single SNP for a
complex phenotype. We also observed marginal evidence
(P ¼ 0.053) for a gender-by-genotype interaction in the off-
spring, suggesting that, in contrast to CPS1, there may be a
stronger effect of this SNP in males than in females. These
findings are consistent with several reports that have suggested
that the effect of MTHFR C677T is stronger in males than in
females (10,19–21) and that the importance of MTHFR
C677T genotype decreases with increasing age (22), although
no evidence for gender differences was reported in the PRO-
CARDIS replication sample (13). Hcy levels have been
shown to be consistently higher in males than in females
after childhood (23,24), and estrogen lowers plasma Hcy
(25). In our study, CHLNS male offspring had significantly
higher mean Hcy levels (P , 0.0001) than female offspring
despite higher mean dietary intake of folate, vitamin B6 and
vitamin B12 (Supplementary Material, Table S2), suggesting
that any increase in the effect of MTHFR C677T genotype
in CLHNS male offspring compared with female offspring is
not due to lower folate intake.
Evidence for differences in genotype effects between the
CLHNS mothers and offspring was also detected at CPS1.
In contrast to MTHFR, the observed effect of CPS1 was stron-
ger in the mothers than in the offspring (Table 1). The differ-
ence in effects for CPS1 could be due to bias based on the
identification of this locus in the mothers and only following
up the most significant results in the offspring, although this
bias is mitigated by the report of the CPS1 association in
the WGHS. The differences in genetic effect strength
Table 1. Evidence of log-Hcy association with CPS1 rs7422339 and MTHFR C677T
n P-value for additive effecta b-Coefficient (SE)a R2 (%) Genotypic least-square means
for Hcy
CPS1 rs7422339 CC CA AA
Mothers 1746 5.3  10212 0.071 (0.009) 3.0 11.02 11.92 12.46
Female offspring 759 0.0087 0.040 (0.015) 0.9 10.46 10.98 11.60
Male offspring 920 0.93 0.001 (0.017) ,0.1 14.36 14.50 13.78
All offspring 1679 0.11 0.021 (0.012) 0.2 12.58 12.91 12.79
Combined mothers þ offspring 3425 5.4  1029 0.050 (0.008) 1.1 11.80 12.43 12.79
MTHFR C677T CC CT TT
Mothers 1769 8.7  10210 0.083 (0.015) 1.6 11.25 11.94 22.17
Female offspring 753 3.6  10210 0.136 (0.022) 5.1 10.42 11.46 21.43
Male offspring 923 1.1  10216 0.199 (0.023) 7.3 13.81 16.38 35.11
All offspring 1676 1.9  10226 0.171 (0.016) 6.3 12.28 14.22 29.13
Combined mothers þ offspring 3445 1.3  10229 0.129 (0.012) 3.3 11.80 12.44 12.86
Results of directly genotyped SNPs are shown.
aFor tests of association and effect estimation, natural log-Hcy was used. b-Coefficients and SEs are reported for an additive effect.
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between CLHNS mothers and their offspring could also be
attributed to age or other factors. We observed no evidence
for a CPS1–age interaction in the mothers, where there is
an age range of 34 years (data not shown). Nonetheless,
there remains the possibility that the difference may not be a
linear effect with age, but rather a consequence of different
life stages or environmental exposures between younger and
older adults.
Effect sizes appear substantially different between CLHNS
and WGHS women at both the CPS1 and MTHFR loci.
Overall mean levels of Hcy were the same (CLHNS mean ¼
11.4, WGHS mean ¼ 11.4), but CLHNS mothers’ Hcy levels
had less variability [CLHNS standard deviation (SD) ¼ 3.0,
WGHS SD ¼ 4.7]. CPS1 SNP rs7422339 was estimated to
explain a greater proportion of the variability in log-Hcy
levels in the CLHNS mothers (R2 ¼ 3.0%) than in the WGHS
samples (R2 ¼ 0.3%) (13) despite a lower frequency (0.24
versus 0.31) of the minor allele in CLHNS mothers. Similarly,
MTHFR C677T explained a greater proportion of the
variability in log-Hcy levels in CLHNS mothers than in
WGHS women (CLHNS R2 ¼ 1.6%; WGHS R2 ¼ 0.95%)
despite a lower estimated frequency of the minor allele (0.22
versus 0.33). At both loci, a significantly higher estimated
increase of log-Hcy levels per each additional copy of the
minor allele was observed in CLHNS mothers compared with
WGHS women (see Table 2 for effect size estimates and their
associated SEs for both studies). The estimated proportions
of variability explained by CPS1 SNP rs7422339 (R2 ¼ 0.9%)
and MTHFR C677T (R2 ¼ 5.1%) in CLHNS female offspring
were also higher than in WGHS women, although the estimated
increase in log-Hcy levels per minor allele for rs7422339 in
CLHNS female offspring was less than the estimated increase
observed in WGHS women. The higher estimated proportion
of variation explained by rs7422339 in CLHNS female off-
spring can be attributed to the lower overall variability of Hcy
levels in CLHNS female offspring (SD ¼ 3.0) compared with
WGHS.
Because environmental factors, such as dietary intake of
folate, vitamin B6 and vitamin B12, and indicators of estrogen
levels in women are predictive of the Hcy level, it is possible
that differences across populations could play a role in how
genes influence Hcy. Both CLHNS and WGHS Hcy measure-
ments were made in environments in which folate and vitamin
B12 fortification was not widely available (WGHS measure-
ments were made prior to 1998, when fortification of refined
wheat products became mainstream in the USA). Adjustment
for folate, vitamin B6 and vitamin B12 did not appreciably
change genetic association test results in either CLHNS
sample. We also found no evidence for any interactions
between either CPS1 rs7422339 or MTHFR C677T genotype
and folate levels to suggest their genotypic effects are stronger
in those with lower reported intake levels of folate. Other
important differences to consider when comparing results
from CLHNS mothers with other studies include substantially
lower use of hormone replacement therapy (,1%), which was
widely reported in the WGHS (44.9%), and low oral contra-
ceptive use in CLHNS (,2%).
Three of the four other loci identified in the WGHS for which
SNP genotypes were available in the CLHNS also showed evi-
dence of association (P , 0.05, Table 2). Evidence for the
NOX4 locus (rs11018628) was relatively strong in the
CLHNS mothers (P ¼ 9.8 1025), and we observed modest
evidence for rs460879 (P ¼ 0.0039) at CHMP1A-DPEP1 and
rs4267943 (P ¼ 0.050) at CENPQ-MUT, but not for
rs2061821 at AKAP13 (P ¼ 0.79). The direction of estimated
effects in the CLHNS mothers was consistent with those
observed in the WGHS for the NOX4, CHMP1A-DPEP1 and
CENPQ-MUT SNPs. We did not observe evidence for the repli-
cation of rs10986018 at GPR51 reported in a meta-analysis by
Hazra et al. (14). The GPR51 C allele frequency, however, was
much smaller in the CLHNS (,0.01) than in the
European-ancestry based sample examined in that study.
Finally, we did not replicate an observed association for
rs1999594 near MTHFR (13,14), for which a joint analysis
including MTHFR SNPs rs1801133 and rs1999594 showed
that both SNPs were significant (14). The frequency of the
rs1999594 minor allele was lower in CLHNS mothers com-
pared with the previous reports; however, there was no evi-
Table 2. Evidence of association in CLHNS mothers at previously reported GWA loci
SNP Nearby
gene






rs7422339 CPS1 2 211 248 752 A 0.31 0.027+0.004 1.9  10211 0.24 0.076+0.011 4.7  10213
rs1801133b MTHFR 1 11 778 965 T 0.33 0.048+0.004 8.1  10235 0.22 0.083+0.015 8.7  10210
rs11018628 NOX4 11 88 846 159 G 0.07 20.050+0.007 9.6  10212 0.07 20.059+0.015 9.8  1025
rs460879 CHMP1A 16 88 240 390 A 0.46 0.026+0.004 3.8  10212 0.53 0.024+0.008 0.0039
rs4267943 CENPQ 6 49 547 764 A 0.36 0.024+0.004 2.0  1029 0.26 0.018+0.009 0.050
rs10986018 GPR51 9 98 202 891 C 0.22 20.06+0.01 2.1  1028 ,0.01 20.120+0.092 0.19
rs2061821 AKAP13 15 83 923 658 A 0.38 0.019+0.004 5.5  1027 0.39 0.002+0.008 0.79
rs1999594 MTHFR 1 11 893 482 G 0.43 0.04+0.01 6.2  10210 0.30 20.002+0.009 0.87
rs6586282 CBS 21 43 351 566 A 0.18 20.030+0.005 3.2  10210 — — —
SNPs previously reported to be associated with Hcy in GWA studies are from reference (13) except rs10986018 and rs1999594, which are from reference (14).
Chromosomal positions are Build 36. SNPs are arranged in ascending order according to CLHNS P-value.
ab-Coefficient for additive effect with respect to the reference allele.
bSNP rs1801133 was poorly imputed, instead the directly genotyped results are reported here. The following SNPs were imputed (imputation quality score):
rs7422339 (0.76), rs11018628 (.0.99), rs460879 (0.96), rs10986018 (0.65), rs2061821 (0.97), rs1999594 (0.83). SNP rs10986018 was not analyzed in the GWA
analysis due to MAF (,0.01). CBS SNP rs6586282 was neither genotyped nor successfully imputed.
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dence of a main effect for this locus (b ¼ 20.002) in CLHNS
mothers. The different results for rs1999594 in CLHNS may
be influenced by weaker linkage disequilibrium (LD)
between rs1801133 and rs1999594 (HapMap CHB þ JPT
R2 ¼ 0.00, D0 ¼ 0.23; HapMap CEU R2 ¼ 0.26, D0 ¼ 0.91).
This study represents the first GWA results for Hcy in an
Asian population. Our findings suggest that at least some of
the main genetic factors influencing plasma Hcy levels are
likely shared across populations of European and Asian
descent, despite different genetic backgrounds and environ-
mental and dietary exposures. These results also suggest that
the effects of genotype on plasma Hcy levels may differ
across gender and life stages and should motivate future
studies to take these factors into consideration.
MATERIALS AND METHODS
Study population and phenotypes
Data and samples come from the CLHNS, a community-based
birth cohort study that originally enrolled 3327 pregnant
women in 1983–84 (3080 singleton live births), and has
since followed them and their offspring to the present (26).
In 2005, 1895 healthy Filipino mothers and 1775 of their off-
spring remained in the study and had DNA and measurement
of biomarkers available.
Trained field staff conducted in-home interviews and col-
lected anthropometric measurements and comprehensive
environmental data at each visit (data available online at
http://www.cpc.unc.edu/projects/cebu/). Blood samples, which
were used for biomarker measurement and DNA extraction,
were obtained in 2005. Plasma Hcy was measured using the
automated Bayerw ADVIA Centaur chemiluminescent Hcy
assay, as described (27).
Dietary intake data were collected via 24 h recall by trained
study personnel during the 2005 visit. Intake was measured for
2 days, and the mean was used in the analysis. Nutrient intakes
of folate, vitamin B6 and vitamin B12 were estimated using the
Philippines Food Composition Tables (28,29).
Sample characteristics for the CLHNS mothers and off-
spring by gender are presented in Supplementary Material,
Tables S1 and S2. Informed consent was obtained from all
CLHNS subjects, and the study protocol was approved by
the University of North Carolina Institutional Review Board
for the Protection of Human Subjects.
GWA SNP genotyping
SNP genotyping was performed with the Affymetrix Genome-
Wide Human SNP Array 5.0 at the Vanderbilt Microarray
Shared Resource at Vanderbilt University Medical Center,
Nashville, TN, USA, using the standard protocol rec-
ommended by the manufacturer. Genotype calling was per-
formed using Birdseed (version 2). Genotyping was
attempted on the 1895 unique CLHNS mothers samples, 40
CLHNS duplicates and 5 HapMap CEPH trios. Ten CLHNS
samples failed genotyping, and four CLHNS samples were
removed after genotyping for a call rate ,97%. The final
call rate across the 1881 remaining samples was 99.6%.
We applied SNP quality control checks in PLINK v1.02 on
the 1881 CLHNS samples that were successfully genotyped
(30). Of the initial 424 670 SNPs, we discarded 13 287
SNPs due to poor mapping, call rates ,90% and/or deviation
from Hardy–Weinberg equilibrium (P , 1026). An additional
164 SNPs were dropped due to three or more discrepancies
between genotypes in 40 duplicate pairs and/or Mendelian
inheritance errors in five CEPH trios. Another 3113 SNPs
were dropped due to three or more genotype discrepancies
with HapMap genotypes.
Additional SNP genotyping
Follow-up genotyping was performed for three SNPs
(rs7422339, rs1801133 and rs6722617) in the CLHNS
mothers and offspring using TaqMan allelic discrimination
(Applied Biosystems, Foster City, CA, USA). The SNPs
rs7422339 and rs6722617 were genotyped to confirm results
for the genetic regions with the strongest evidence for associ-
ation with Hcy at which the most significant SNP in the region
was imputed (see below), and to test for evidence of associ-
ation in the CLHNS offspring. MTHFR C677T (rs1801133)
was genotyped because it had a low imputation quality score
(R2 , 0.3, where R is the estimated correlation between the
imputed genotype calls and the true unknown genotype for
the SNP) in the CLHNS mothers and was an important a
priori candidate SNP. The genotype success rate for all
SNPs was .98% and no discrepancies were observed
among duplicate samples (discrepancy rate ,0.3%).
Population relatedness
We used identity-by-descent and identity-by-state estimates
calculated in PLINK in combination with our prior knowledge
of relationships between CLHNS participants to eliminate 81
estimated first-degree relatives. Our final sample for GWA
analysis consisted of 1786 CLHNS women with available gen-
otypes, Hcy levels and covariates from the 2005 survey.
SNP imputation
Using a hidden Markov model algorithm implemented in
MACH software version 1.0 (available online at http://www.
sph.umich.edu/csg/abecasis/mach/), genotype imputation was
conducted using 352 264 directly genotyped SNPs that were
polymorphic in both the 60 CEU founders and the 89 com-
bined CHB þ JPT HapMap samples (31). We pooled haplo-
types from phased chromosomes in these two HapMap
populations to better capture the LD structure in our CLHNS
samples. We have shown previously that the CHB HapMap
population is a reasonable proxy to the CLHNS cohort (32).
For each subject, the genotype for each SNP was reported as
a dosage value (a continuous number between 0 and 2) that
reflects the expected number of copies of an arbitrary allele
at that SNP conditional on the directly observed genotypes
in both the subject and a representative sample of 200 unre-
lated CLHNS subjects and the phased haplotype assignments
in the CEU and CHB þ JPT HapMap samples. Imputation
yielded genotype data for 1 878 188 new SNPs, and the
352 264 directly genotyped SNPs were also assigned
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imputed genotypes. We used R2  0.3 as a quality control
threshold to discard 150 177 low-quality imputed SNPs, and
also excluded 30 351 SNPs with estimated minor allele fre-
quencies (MAF)  0.01. Finally, discrete dosage values of
0, 1 or 2 were assigned for 23 750 directly genotyped SNPs
non-polymorphic in either HapMap sample (and therefore
not imputed) but with MAF . 0.01 in the CLHNS samples.
In total, 2 073 674 SNPs were tested for association with the
Hcy level.
Accounting for population substructure
We constructed PCs using the software EIGENSOFT to
capture population substructure among our CHLNS subjects
(33). We identified a set of 13 972 independent SNPs (esti-
mated R2 , 0.005 between all pairs of SNPs within 1 Mb)
with observed MAF . 0.05. The PCs were constructed on
the basis of these 13 972 SNPs and 1571 CHLNS subjects
with estimated genome-wide pair-wise identity-by-descent
,0.1. The PCs for the remaining 228 subjects were sub-
sequently calculated using the parameter coefficients obtained
from the first 1571 subjects. The corresponding eigenvalues
for the individual PCs were plotted (data not shown) and
‘the elbow’ of the eigenvalue plot was used to define which
PCs to be included as covariates in association analyses. A
plot of the first versus the second PC is shown in Supplemen-
tary Material, Figure S1. In addition, we tested for the associ-
ation between each of the first 10 PCs and the Hcy level to
confirm that any important ancestry explanatory PC was
included. The first three PCs were included as covariates in
the linear regression models. Finally, we examined the calcu-
lated genomic control value to evaluate for systematic P-value
inflation due to cryptic relatedness between samples not
accounted for by the analytic adjustment for PCs in the
regression analyses (34).
GWA association analysis
Hcy level was natural log-transformed (log-Hcy) to satisfy the
model assumption of normally distributed residuals after
adjustment for the covariates of age, number of previous preg-
nancies (categorized as 0–4, 5–10, 11), menopausal status
and the first three PCs from the population substructure analy-
sis (Supplementary Material, Table S4). Array Studio software
version 3.1 was used to perform the initial GWA analyses
(Array Studio and all other Omicsoft products or service
names are registered trademarks or trademarks of Omicsoft
Corporation, Research Triangle Park, NC, USA). Multiple
linear regression was used to test for the association between
log-Hcy and each SNP, with adjustment for covariates. Geno-
type was modeled as an additive effect, with the genotype
dosage values used as the primary predictor of interest. A 1
degree-of-freedom likelihood ratio test was used to assess stat-
istical significance. A significance threshold of P , 5  1028
was used to define a single result as genome-wide significant.
Quantile–quantile plots of observed versus expected –log10(-
P-values) were constructed to help assess any cumulative
inflation or deflation of statistical significance estimates com-
pared with expectation under the null hypothesis. To compare
effect sizes with one study that did not report SEs (13), SE
estimates for the additive genetic effect b-coefficients were
derived from the reported estimated b-coefficients and their
corresponding Wald test P-values.
Follow-up association analysis on CLHNS mothers
and offspring
Linear regression models were analyzed in the software
package SAS version 9.3 (SAS Inc., Cary, NC, USA) to test
the genotyped SNPs rs7422339, rs6722617 and rs1801133
for association with log-Hcy separately in the mother and
the offspring samples. In the offspring sample, we adjusted
only for gender, because the ages of all offspring were
within 2 years of each other, menopause status was not rel-
evant and the number of previous pregnancies and PCs for
population stratification were not available. Genotype was
modeled as an additive effect. Partial correlations were calcu-
lated for each locus to estimate the proportion of variation
explained by genotype. In the offspring sample, we further
performed analyses stratified by gender and tests of
gender-by-genotype interaction to assess whether results
were similar for males and females. We also tested for evi-
dence of a genotype-by-genotype interaction effect between
CPS1 rs7422339 and MTHFR C677T on the Hcy level.
We used general linear mixed models to evaluate genotype
effects on the combined sample of mothers and offspring
while accounting for the correlation of Hcy levels between
mother–child pairs due to shared environmental and genetic
exposures. Within this setting, we also conducted tests of
interaction to assess whether the effects for each locus were
similar in mothers and offspring. A significance threshold of
P , 0.05 was used for tests of interaction. We repeated the
mother–offspring-stratified and -combined analyses with
additional adjustment for estimated dietary folate, vitamin
B6 and vitamin B12 intake to assess whether adjustment for
these factors appreciably changed genetic association results.
Finally, we tested for interactions between genotype and
folate levels to assess whether there were stronger genetic
effects in subjects with lower reported folate levels.
Conditional analysis for CPS1 SNPs
To evaluate whether any of the other 21 CPS1 SNPs with P ,
5  1028 were independently associated with log-Hcy levels
in the CLHNS mothers after accounting for the strongest
associated SNP (rs7422339), we performed association ana-
lyses for the CPS1 SNPs conditioning on rs7422339 genotype.
Using SAS, we examined tests of additive genotype effects for
each of the 21 SNPs in individual linear regression models
with the same covariates as above plus the rs7422339 geno-
type.
Association of CPS1 SNP rs7422339 with additional traits
We tested the CPS1 SNP rs7422339 for association with
several additional biomarkers associated with CVD: total
cholesterol, HDL-C, LDL-C, triglycerides, CRP, fasting
glucose and BMI. Outcome traits were first natural log-
transformed and adjusted for the same covariates as for
the Hcy analysis. Any associations that were found to be
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nominally significant (P , 0.05) were further tested adding
the Hcy level to the model to evaluate whether the association
was independent of the phenotype’s correlation with Hcy.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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